Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Prev Med. 2020 Oct 3;141:106267. doi: 10.1016/j.ypmed.2020.106267

Table 2.

Adjusteda mean outcome measures at each visit and mean change from baseline to 2, 6, 12, and 18 months.

F&S! Plus F&S!



Outcomes over time Outcome measure Change from baseline Outcome measure Change from baseline Significance of difference in mean change between groups Significance of overall group*visit interaction



Mean ± SE Meanb ± SE %c pd (N) Mean ± SE Meanb ± SE %c pd (N) pe p
Weight, kg < .0001
Baseline 93.1 ± 1.1 (N = 203) 93.7 ± 1.1 (N = 210)
2 Mon 91.2 ± 1.1 −2.0 ± 0.2 −2.1% *** (N = 191) 93.2 ± 1.1 −0.5 ± 0.2 −0.6% ** (N = 191) < 0.0001
6 Mon 91.1 ± 1.1 −2.0 ± 0.3 −2.2% *** (N = 175) 92.9 ± 1.1 −0.8 ± 0.3 −0.9% ** (N = 171) 0.0009
12 Mon 91.4 ± 1.1 −1.7 ± 0.3 −1.8% *** (N = 154) 92.8 ± 1.1 −0.9 ± 0.3 −1.0% ** (N = 168) 0.049
18 Mon 91.8 ± 1.2 −1.3 ± 0.3 −1.4% *** (N = 174) 92.8 ± 1.2 −0.9 ± 0.3 −1.0% ** (N = 181) 0.40
BMI, kg/m2 < 0.0001
Baseline 34.7 ± 0.4 (N = 203) 35.0 ± 0.4 (N = 210)
2 Mon 34.0 ± 0.4 −0.7 ± 0.1 −2.1% *** (N = 191) 34.8 ± 0.4 −0.2 ± 0.1 −0.5% ** (N = 191) < 0.0001
6 Mon 34.0 ± 0.4 −0.8 ± 0.1 −2.2% *** (N = 175) 34.7 ± 0.4 −0.3 ± 0.1 −0.9% ** (N = 171) 0.0009
12 Mon 34.1 ± 0.4 −0.6 ± 0.1 −1.9% *** (N = 154) 34.7 ± 0.4 −0.3 ± 0.1 −0.9% ** (N = 168) 0.04
18 Mon 34.2 ± 0.4 −0.5 ± 0.1 −1.4% *** (N = 174) 34.7 ± 0.4 −0.3 ± 0.1 −0.9% ** (N = 181) 0.39
Waist circumference, cm 0.0003
Baseline 113.9 ± 0.5 (N = 201) 111.8 ± 0.5 (N = 210)
2 Mon 111.1 ± 0.5 −2.9 ± 0.4 −2.5% *** (N = 191) 111.3 ± 0.5 −0.5 ± 0.4 −0.4% (N = 191) < 0.0001
6 Mon 110.5 ± 0.6 −3.4 ± 0.5 −3.0% *** (N = 175) 110.8 ± 0.6 −1.0 ± 0.5 −0.9% (N = 171) 0.0006
12 Mon 111.2 ± 0.7 −2.7 ± 0.6 −2.4% *** (N = 155) 111.4 ± 0.6 −0.4 ± 0.6 −0.3% (N = 168) 0.004
18 Mon 111.9 ± 0.7 −2.0 ± 0.5 −1.8% *** (N = 174) 110.4 ± 0.6 −1.4 ± 0.5 −1.2% * (N = 181) 0.39
Healthy Eating Index 2010f 0.004
Baseline 65.9 ± 0.7 (N = 197) 66.7 ± 0.7 (N = 203)
2 Mon 70.6 ± 0.7 4.7 ± 0.7 7.1% *** (N = 183) 68.8 ± 0.7 2.1 ± 0.7 3.1% ** (N = 185) 0.005
6 Mon 67.9 ± 0.8 2.0 ± 0.7 3.1% ** (N = 166) 67.5 ± 0.8 0.8 ± 0.7 1.2% (N = 161) 0.24
12 Mon 66.4 ± 0.7 0.6 ± 0.7 0.9% (N = 150) 68.0 ± 0.7 1.3 ± 0.7 2.0% (N = 158) 0.47
18 Mon 66.9 ± 0.8 1.0 ± 0.7 1.5% (N = 164) 66.7 ± 0.8 0.0 ± 0.7 0.0% (N = 169) 0.33
PASE physical activity scoreg 0.23
Baseline 99.6 ± 4.2 (N = 199) 99.2 ± 4.2 (N = 210)
2 Mon 128.7 ± 4.9 29.1 ± 4.8 29.2% *** (N = 184) 113.3 ± 5.0 14.1 ± 4.7 14.2% ** (N = 184) 0.03
6 Mon 117.1 ± 5.2 17.5 ± 5.0 17.6% *** (N = 172) 114.6 ± 5.2 15.4 ± 5.0 15.5% ** (N = 169) 0.77
12 Mon 111.2 ± 5.0 11.6 ± 4.9 11.7% * (N = 153) 106.2 ± 4.9 7.0 ± 4.8 7.0% (N = 163) 0.50
18 Mon 111.7 ± 4.8 12.2 ± 4.9 12.2% * (N = 171) 104.4 ± 4.8 5.2 ± 4.8 5.3% (N = 178) 0.32
WOMAC pain (0−20)h 0.004
Baseline 5.4 ± 0.2 (N = 203) 5.7 ± 0.2 (N = 210)
2 Mon 4.1 ± 0.2 −1.4 ± 0.2 −25.1% *** (N = 191) 5.2 ± 0.2 −0.5 ± 0.2 −8.8% * (N = 192) 0.01
6 Mon 3.9 ± 0.3 −1.5 ± 0.3 −27.2% *** (N = 174) 5.1 ± 0.3 −0.6 ± 0.3 −11.1% * (N = 173) 0.03
12 Mon 4.5 ± 0.3 −0.9 ± 0.3 −16.7% ** (N = 156) 5.0 ± 0.3 −0.7 ± 0.3 −12.0% * (N = 169) 0.57
18 Mon 4.5 ± 0.3 −0.9 ± 0.3 −16.4% ** (N = 174) 4.8 ± 0.3 −1.0 ± 0.3 −16.7% ** (N = 182) 0.88
WOMAC physical function (0–68)h 0.004
Baseline 17.7 ± 0.9 (N = 203) 17.8 ± 0.9 (N = 210)
2 Mon 12.2 ± 0.9 −5.5 ± 0.8 −31.0% *** (N = 191) 15.8 ± 0.9 −1.9 ± 0.7 −10.8% * (N = 191) 0.0009
6 Mon 12.8 ± 1.0 −4.9 ± 0.9 −27.5% *** (N = 174) 16.1 ± 1.0 −1.7 ± 0.9 −9.4% * (N = 173) 0.01
12 Mon 13.6 ± 0.9 −4.1 ± 0.9 −23.4% *** (N = 156) 15.7 ± 0.9 −2.0 ± 0.9 −11.5% (N = 169) 0.09
18 Mon 14.2 ± 1.0 −3.5 ± 0.9 −19.5% *** (N = 174) 15.2 ± 1.0 −2.6 ± 0.9 −14.7% ** (N = 182) 0.48
WOMAC stiffness (0–8)h 0.049
Baseline 3.1 ± 0.1 (N = 203) 3.2 ± 0.1 (N = 210)
2 Mon 2.4 ± 0.1 −0.6 ± 0.1 −21.2% *** (N = 191) 2.9 ± 0.1 −0.3 ± 0.1 −10.2% ** (N = 192) 0.06
6 Mon 2.6 ± 0.1 −0.5 ± 0.1 −15.5% *** (N = 174) 2.7 ± 0.1 −0.5 ± 0.1 −15.9% *** (N = 173) 0.81
12 Mon 2.6 ± 0.1 −0.5 ± 0.1 −15.2% *** (N = 156) 2.7 ± 0.1 −0.6 ± 0.1 −17.6% *** (N = 169) 0.57
18 Mon 2.6 ± 0.1 −0.4 ± 0.1 −13.4% ** (N = 174) 2.6 ± 0.1 −0.6 ± 0.1 −18.3% *** (N = 182) 0.32
Six-minute walk, m 0.0005
Baseline 360.8 ± 6.2 (N = 201) 357.7 ± 6.2 (N = 208)
2 Mon 411.2 ± 6.8 50.5 ± 4.4 14.0% *** (N = 190) 380.6 ± 6.8 22.9 ± 4.4 6.4% *** (N = 189) < 0.0001
6 Mon 390.1 ± 7.3 29.3 ± 5.1 8.1% *** (N = 173) 371.0 ± 7.3 13.3 ± 5.2 3.7% * (N = 165) 0.03
12 Mon 384.0 ± 7.5 23.2 ± 5.3 6.4% *** (N = 154) 367.7 ± 7.4 10.0 ± 5.3 2.8% (N = 164) 0.08
18 Mon 373.5 ± 7.7 12.8 ± 5.8 3.5% * (N = 168) 357.2 ± 7.7 −0.6 ± 5.8 −0.2% (N = 173) 0.10
Chair stands in 30 s 0.26
Baseline 8.8 ± 0.2 (N = 203) 8.8 ± 0.2 (N = 209)
2 Mon 10.6 ± 0.2 1.8 ± 0.2 20.4% *** (N = 187) 10.2 ± 0.2 1.3 ± 0.2 15.0% *** (N = 188) 0.08
6 Mon 10.4 ± 0.3 1.7 ± 0.2 18.8% *** (N = 172) 10.0 ± 0.3 1.1 ± 0.2 13.0% *** (N = 165) 0.07
12 Mon 10.4 ± 0.3 1.6 ± 0.2 18.3% *** (N = 152) 9.8 ± 0.3 1.0 ± 0.2 11.4% *** (N = 162) 0.046
18 Mon 10.2 ± 0.3 1.4 ± 0.2 15.5% *** (N = 170) 9.6 ± 0.3 0.7 ± 0.2 8.2% ** (N = 176) 0.045
Anxiety and depression (0−10)i 0.26
Baseline 2.5 ± 0.1 (N = 203) 2.6 ± 0.1 (N = 210)
2 Mon 2.0 ± 0.1 −0.5 ± 0.1 −19.9% *** (N = 191) 2.2 ± 0.1 −0.4 ± 0.1 −13.8% *** (N = 190) 0.26
6 Mon 2.1 ± 0.1 −0.4 ± 0.1 −15.9% *** (N = 174) 2.4 ± 0.1 −0.1 ± 0.1 −5.8% (N = 173) 0.07
12 Mon 2.1 ± 0.1 −0.4 ± 0.1 −15.1% *** (N = 156) 2.4 ± 0.1 −0.1 ± 0.1 −5.0% (N = 169) 0.08
18 Mon 2.2 ± 0.1 −0.3 ± 0.1 −12.2% ** (N = 174) 2.3 ± 0.1 −0.2 ± 0.1 −9.3% * (N = 182) 0.66
a

From repeated-measures linear models with a fully specified (unstructured) covariance matrix and the baseline value included in the outcome vector. Covariates included in models: Iteration, baseline WOMAC physical function (except for the WOMAC physical function model), and baseline BMI (except for the weight and BMI models).

b

Estimated mean change is the difference between the follow-up and baseline adjusted means.

c

Percent change is mean change divided by the adjusted baseline mean.

d

Test for within-group change different from 0

*

p < 0.05

**

p < 0.01

***

p < 0.001.

e

Test for difference in change between groups.

f

A higher score indicates higher diet quality. Records with energy values < 500 or > 5000 kcal were excluded from the analysis: 13 at baseline and 2 months, 20 at 6 months, 16 at 12 months, 22 at 18 months.

g

A higher score indicates greater physical activity.

h

A higher score indicates greater difficulties due to OA.

i

A higher score indicates greater anxiety/depression.